Human restricted CHRFAM7A mediates neuronal and innate immune gain of function
Kinga Szigeti, Ivanna Ihnatovych, Ryu Dorn, Nicolas Rosas, Eduardo Cortes Gomez, Gregory Wilding, Wang Jianmin · 2025
Read Human restricted CHRFAM7A mediates neuronal and innate immune gain of function by Kinga Szigeti, Ivanna Ihnatovych, Ryu Dorn, Nicolas Rosas, Eduardo Cortes Gomez, Gregory Wilding, Wang Jianmin (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11713725.txt.
Description
Kinga Szigeti and co-authors study a human-only gene that reshapes Alzheimer's biology in a 2025 paper. Three quarters of people carry CHRFAM7A, a gene no animal model naturally has. That gap may explain why lab findings so often fail to translate.
Brain tissue data from six hundred donors tied the gene to calcium control and a cytoskeleton switch. Lab-grown human neurons and immune cells carrying the gene showed the predicted structural gains. Spines on neurons matured faster, and immune cells invaded and ate debris more eagerly. Drug response also shifted, since the gene dulls a key receptor. The authors argue most Alzheimer's cases run on this altered background.
Catalog record
| CREATOR | Kinga Szigeti, Ivanna Ihnatovych, Ryu Dorn, Nicolas Rosas, Eduardo Cortes Gomez, Gregory Wilding, Wang Jianmin |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 3 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |